Fig. 1 | Scientific Reports

Fig. 1

From: Multiomics Mendelian randomization integrating pQTL, eQTL and mQTL data revealed BTN3A2 as a potential drug target for nephrolithiasis

Fig. 1

Overview of the study design. UKB-PPP UK Biobank Pharma Proteomics Project, MR Mendelian randomization, GWAS genome-wide association analysis, PPI protein–protein interaction, GFR glomerular filtration rate, BTN2A1 butyrophilin subfamily 2 member A1, BTN3A2 butyrophilin subfamily 3 member A2, ERBB4 receptor tyrosine-protein kinase erbB-4, FKBPL FK506-binding protein-like, HLA-E HLA class I histocompatibility antigen, alpha chain E, UMOD uromodulin, PPRTs plasma protein-related targets, pQTLs protein quantitative trait loci, cis-eQTLs cis expression quantitative trait loci, cis-mQTLs cis-DNA methylation quantitative trait loci.

Back to article page